Switch to EGFR-TKI after upfront platinum doublet induction therapy in non-small cell lung cancer (NSCLC) patients with EGFR (Epidermal Growth Factor Receptor) mutation: A multicen...

Por Susana Baptista de Almeida, Ana Sofia Spencer, Claudia Lares dos Santos, Gonçalo Fernandes, Pedro Simões, Sónia Silva, Tiago Dias Domingues, Marta Honório
Publicado em 2022-01-01